Literature DB >> 17904645

The contribution of nitric oxide and interferon gamma to the regulation of the neuro-inflammation in experimental autoimmune encephalomyelitis.

David O Willenborg1, Maria Staykova, Sue Fordham, Nikki O'Brien, David Linares.   

Abstract

Nitric oxide (NO) is a key messenger involved in physiological functions including endothelium-dependent vascular relaxation, inhibition of platelet adhesion and aggregation and regulation of inflammatory and immune responses. Here we briefly introduce NO and its functions and then describe our work over the past several years examining the role of NO in EAE in both the rat and the mouse. We show that NO plays a significant role in determining the resistance or susceptibility to EAE in various strains and or sexes of animals. We demonstrate that NO down-regulates several aspects of CNS inflammation but also has a dual role in that it is required for inflammation in some situations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17904645     DOI: 10.1016/j.jneuroim.2007.09.007

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  30 in total

1.  Nitric oxide controls an inflammatory-like Ly6C(hi)PDCA1+ DC subset that regulates Th1 immune responses.

Authors:  Daniela Giordano; Chang Li; Mehul S Suthar; Kevin E Draves; Daphne Y Ma; Michael Gale; Edward A Clark
Journal:  J Leukoc Biol       Date:  2010-12-22       Impact factor: 4.962

Review 2.  Mechanisms regulating regional localization of inflammation during CNS autoimmunity.

Authors:  Emily Pierson; Sarah B Simmons; Luca Castelli; Joan M Goverman
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

3.  The influence of sodium nitrite on the locomotor functions of white blood cells.

Authors:  R I Kovalenko; A A Petenkova; E M Tsoi; A D Nozdrachev
Journal:  Dokl Biol Sci       Date:  2009 Jul-Aug

Review 4.  Sleep: a synchrony of cell activity-driven small network states.

Authors:  James M Krueger; Yanhua H Huang; David M Rector; Daniel J Buysse
Journal:  Eur J Neurosci       Date:  2013-05-08       Impact factor: 3.386

5.  Inhibition of TLR ligand- and interferon gamma-induced murine microglial activation by Panax notoginseng.

Authors:  Celine A Beamer; David M Shepherd
Journal:  J Neuroimmune Pharmacol       Date:  2011-12-21       Impact factor: 4.147

6.  GM-CSF-neuroantigen fusion proteins reverse experimental autoimmune encephalomyelitis and mediate tolerogenic activity in adjuvant-primed environments: association with inflammation-dependent, inhibitory antigen presentation.

Authors:  S M Touhidul Islam; Alan D Curtis; Najla Taslim; Daniel S Wilkinson; Mark D Mannie
Journal:  J Immunol       Date:  2014-07-21       Impact factor: 5.422

7.  Mice with a selective impairment of IFN-gamma signaling in macrophage lineage cells demonstrate the critical role of IFN-gamma-activated macrophages for the control of protozoan parasitic infections in vivo.

Authors:  Jennifer E Lykens; Catherine E Terrell; Erin E Zoller; Senad Divanovic; Aurelien Trompette; Christopher L Karp; Julio Aliberti; Matthew J Flick; Michael B Jordan
Journal:  J Immunol       Date:  2009-12-14       Impact factor: 5.422

Review 8.  Nitrosothiols in the immune system: signaling and protection.

Authors:  Pablo Hernansanz-Agustín; Alicia Izquierdo-Álvarez; Almudena García-Ortiz; Sales Ibiza; Juan M Serrador; Antonio Martínez-Ruiz
Journal:  Antioxid Redox Signal       Date:  2012-08-17       Impact factor: 8.401

9.  Autoantigen immunization at different sites reveals a role for anti-inflammatory effects of IFN-gamma in regulating susceptibility to experimental autoimmune encephalomyelitis.

Authors:  Silvia Pastor; Alfredo Minguela; Wentao Mi; E Sally Ward
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

Review 10.  The effects of NOS2 gene deletion on mice expressing mutated human AbetaPP.

Authors:  Carol A Colton; Donna M Wilcock; David A Wink; Judianne Davis; William E Van Nostrand; Michael P Vitek
Journal:  J Alzheimers Dis       Date:  2008-12       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.